GlassScriptPhysician profile
Rose Macalister
NPI 1851721153
$749.54
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $162 · 2022: $460 · 2024: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $126.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $202.21 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $126.85 | 2024 | |
| Biohaven Pharmaceuticals, INC. | $124.43 | 2021 | |
| Amgen INC. | $56.29 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $44.21 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $29.37 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.14 | 2022 | |
| Pfizer INC. | $26.46 | 2022 | |
| Abbvie INC. | $18.78 | 2022 | |
| Nestle Healthcare Nutrition INC. | $17.43 | 2022 | |
| Organon LLC | $16.45 | 2022 | |
| Eisai INC. | $15.45 | 2021 | |
| Janssen Pharmaceuticals, INC | $14.89 | 2022 | |
| Merck Sharp & Dohme LLC | $14.00 | 2022 | |
| Heartflow, INC. | $13.58 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rose Macalister listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.